Pfizer CEO Says Covid Emergency will never end!

– In March 2021, Pfizer execs discuss hiking vaccine price after pandemic wanes. Right before the FDA Approval!

– As of July 2020, Pfizer signed a $1.95 billion pact to provide the U.S. government with 100 million doses of its COVID-19 vaccine. That order was doubled in December 2020 when the company inked another $2 billion deal with former President Trump’s administration.

$400 billion in under 12 months off the tax payers backs!

Would you stop when every year to can bill the government 2-400 billion? Safe or not safe they have complete immunity from legal consequences, that’s why is must remain a “Emergency Use” product.

Documents Reveal FDA Advisers Receive Financial Gain from Drug Companies
Another hidden conflict of interest stems from FDA advisers who are receiving payments or other financial support from pharmaceutical companies. These advisors are meant to be the gatekeepers in determining approval of a drug based on safety and efficacy studies. An investigative article written in Science Mag found that of 107 physician FDA advisers voted on approval committees, 40 of them received more than $10,000 in post hoc earnings or research support, 26 of them received more than $100,000, and six received more than $1 million.17 These payments go unnoticed and entirely unregulated since the payments are not completed until after the advisory panel meets and the individuals declare they have no financial conflicts of interest. Science Mag reports

Pfizer Contributes $1M to Members of Congress, Almost $400,000 to President Biden
Lastly, the pharmaceutical industry has long been a major contributor to members of congress, specifically focusing on those on key committees that oversee healthcare legislation. In 2020, Pfizer contributed roughly $1 million to members of Congress. A Stat News article reported that last year, over two-thirds of Congress cashed a check from a pharmaceutical company. The article states

Leave a Reply

Your email address will not be published.